Our Mission
We’re on a mission to help cure more cancer patients and improve their quality of life, partnering with clinics and treatment centers around the world.
We’re on a mission to help cure more cancer patients and improve their quality of life, partnering with clinics and treatment centers around the world.
To provide superior treatment in radiation oncology for all people with cancer, no matter where they live.
Our positioning and scanning products help take advanced radiation therapy techniques to the next level, ensuring that the radiation dose is delivered to the tumor with extremely high precision and microsecond timing.
The result: more effective, safer treatments for the patient and a more efficient workflow for the clinic.
“C-RAD creates modern solutions for cancer therapy, truly improving individual care and societal needs.”
Cecilia de Leeuw, CEO of C-RAD
C-RAD founded.
Sentinel™, the first product, launched.
First products in clinical use.
C-RAD enters North American market with C-RAD Inc subsidiary.
Catalyst™ system, a next-generation optical surface scanning system, launched.
Tim Thurn is appointed CEO for C-RAD. Catalyst HD™ released.
C-RAD is listed on NASDAQ.
Catalyst released for use in proton and particle therapy.
Innovative laser solutions for patient positioning and virtual simulation added to the C-RAD portfolio with the acquisition of the Franco-Belgian Cyrpa group.
Expanded into workflow for patient and accessory validation. Framework agreement with Elekta signed.
Catalyst+ and Catalyst+HD upgrade is launched.
cAutoVerify is launched. Framework agreement with Accuray signed. C-RAD enters Indian market with subsidiary.
C-RAD enter Australian and New Zealand market with subsidiary. Cecilia de Leeuw appointed as CEO & President on December 21, 2022.
Catalyst+ version 6.5 is launched.
SGRT is a tattoo-free alternative for patients who require radiation therapy. With the elimination of tattoos and elaborate immobilization products, SGRT helps improve the overall treatment experience.
C-RAD monitors the patient’s motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.